BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 35013556)

  • 1. The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin.
    Krastev DB; Li S; Sun Y; Wicks AJ; Hoslett G; Weekes D; Badder LM; Knight EG; Marlow R; Pardo MC; Yu L; Talele TT; Bartek J; Choudhary JS; Pommier Y; Pettitt SJ; Tutt ANJ; Ramadan K; Lord CJ
    Nat Cell Biol; 2022 Jan; 24(1):62-73. PubMed ID: 35013556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Releasing the trap: How the segregase p97 extracts PARP1 from chromatin.
    Götz MJ; Stingele J
    Mol Cell; 2022 Mar; 82(5):889-890. PubMed ID: 35245455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MORC2 regulates DNA damage response through a PARP1-dependent pathway.
    Zhang L; Li DQ
    Nucleic Acids Res; 2019 Sep; 47(16):8502-8520. PubMed ID: 31616951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(ADP‑ribose) polymerase 1/2 inhibitors decrease the ubiquitination of ALC1 mediated by CHFR in breast cancer.
    Wang Y; Wang Y; Wang N; You L; Long F; Shao C; Wang Y; Wu J
    Oncol Rep; 2019 Oct; 42(4):1467-1474. PubMed ID: 31322269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serine-linked PARP1 auto-modification controls PARP inhibitor response.
    Prokhorova E; Zobel F; Smith R; Zentout S; Gibbs-Seymour I; Schützenhofer K; Peters A; Groslambert J; Zorzini V; Agnew T; Brognard J; Nielsen ML; Ahel D; Huet S; Suskiewicz MJ; Ahel I
    Nat Commun; 2021 Jul; 12(1):4055. PubMed ID: 34210965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Ubiquitin Ligase TRIP12 Limits PARP1 Trapping and Constrains PARP Inhibitor Efficiency.
    Gatti M; Imhof R; Huang Q; Baudis M; Altmeyer M
    Cell Rep; 2020 Aug; 32(5):107985. PubMed ID: 32755579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone ADP-ribosylation promotes resistance to PARP inhibitors by facilitating PARP1 release from DNA lesions.
    Zentout S; Imburchia V; Chapuis C; Duma L; Schützenhofer K; Prokhorova E; Ahel I; Smith R; Huet S
    Proc Natl Acad Sci U S A; 2024 Jun; 121(25):e2322689121. PubMed ID: 38865276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of the SUMO-related enzymes, PIAS1, PIAS4, and RNF4, in DNA double-strand break repair by homologous recombination.
    Han MM; Hirakawa M; Yamauchi M; Matsuda N
    Biochem Biophys Res Commun; 2022 Feb; 591():95-101. PubMed ID: 35007836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitin-SUMO circuitry controls activated fanconi anemia ID complex dosage in response to DNA damage.
    Gibbs-Seymour I; Oka Y; Rajendra E; Weinert BT; Passmore LA; Patel KJ; Olsen JV; Choudhary C; Bekker-Jensen S; Mailand N
    Mol Cell; 2015 Jan; 57(1):150-64. PubMed ID: 25557546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Avoid the trap: Targeting PARP1 beyond human malignancy.
    Kim C; Chen C; Yu Y
    Cell Chem Biol; 2021 Apr; 28(4):456-462. PubMed ID: 33657415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.
    Hu K; Wu W; Li Y; Lin L; Chen D; Yan H; Xiao X; Chen H; Chen Z; Zhang Y; Xu S; Guo Y; Koeffler HP; Song E; Yin D
    EMBO Rep; 2019 May; 20(5):. PubMed ID: 30940648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Myc is targeted to the proteasome for degradation in a SUMOylation-dependent manner, regulated by PIAS1, SENP7 and RNF4.
    González-Prieto R; Cuijpers SA; Kumar R; Hendriks IA; Vertegaal AC
    Cell Cycle; 2015; 14(12):1859-72. PubMed ID: 25895136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revisiting PARP2 and PARP1 trapping through quantitative live-cell imaging.
    Zhang H; Lin X; Zha S
    Biochem Soc Trans; 2022 Aug; 50(4):1169-1177. PubMed ID: 35959996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PIASy mediates SUMO-2/3 conjugation of poly(ADP-ribose) polymerase 1 (PARP1) on mitotic chromosomes.
    Ryu H; Al-Ani G; Deckert K; Kirkpatrick D; Gygi SP; Dasso M; Azuma Y
    J Biol Chem; 2010 May; 285(19):14415-23. PubMed ID: 20228053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PARP-1 transcriptional activity is regulated by sumoylation upon heat shock.
    Martin N; Schwamborn K; Schreiber V; Werner A; Guillier C; Zhang XD; Bischof O; Seeler JS; Dejean A
    EMBO J; 2009 Nov; 28(22):3534-48. PubMed ID: 19779455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNF4-mediated SUMO-targeted ubiquitination relieves PARIS/ZNF746-mediated transcriptional repression.
    Nishida T; Yamada Y
    Biochem Biophys Res Commun; 2020 May; 526(1):110-116. PubMed ID: 32197837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased PARP1-DNA binding due to autoPARylation inhibition of PARP1 on DNA rather than PARP1-DNA trapping is correlated with PARP1 inhibitor's cytotoxicity.
    Chen HD; Chen CH; Wang YT; Guo N; Tian YN; Huan XJ; Song SS; He JX; Miao ZH
    Int J Cancer; 2019 Aug; 145(3):714-727. PubMed ID: 30675909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PARP1: A Promising Target for the Development of PARP1-based Candidates for Anticancer Intervention.
    Zhu X; Ma X; Hu Y
    Curr Med Chem; 2016; 23(17):1756-74. PubMed ID: 25245372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(ADP-ribose)polymerase (PARP) inhibition and anticancer activity of simmiparib, a new inhibitor undergoing clinical trials.
    Yuan B; Ye N; Song SS; Wang YT; Song Z; Chen HD; Chen CH; Huan XJ; Wang YQ; Su Y; Shen YY; Sun YM; Yang XY; Chen Y; Guo SY; Gan Y; Gao ZW; Chen XY; Ding J; He JX; Zhang A; Miao ZH
    Cancer Lett; 2017 Feb; 386():47-56. PubMed ID: 27847302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CHFR-mediated degradation of RNF126 confers sensitivity to PARP inhibitors in triple-negative breast cancer cells.
    Wu W; Zhao J; Xiao J; Wu W; Xie L; Xie X; Yang C; Yin D; Hu K
    Biochem Biophys Res Commun; 2021 Oct; 573():62-68. PubMed ID: 34388456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.